Abstract
In highly developed countries like USA, approximately one out of 6 in the male population will expect to have prostate cancer in their life time. Chemoprevention is presumably one of most effective means to combat many types of cancer including prostate cancer (PCa). Because clinically significant PCa usually requires more than a decade to develop, therefore, it would be an ideal target for chemoprevention. This review will focus on recent findings of the most studied, naturally occurring, synthetic or semi-synthetic chemicals for potential use in preventing PCa. Newly discovered chemicals which show potential in preventative or therapeutic effects will be included. Molecular mechanisms and gene/pathway targets by which the above agents act on target cells will be briefly discussed. The recent findings on the chemicals possessing anti-androgen receptor, anti-DNA methyltransferase, or anti-histone deacetyltransferase activity will also be presented. It will further present some important issues regarding how the interactions of chemopreventing agents with genetic polymorphisms or epigenetic factors might affect anti-cancer effects of the agents. Related large trials, if appropriate, will also be discussed.
Keywords: Prostate cancer, dietary chemicals, chemoprevention, epigenetic, genetic polymorphism
Current Cancer Drug Targets
Title: Recent Approaches in Chemoprevention of Prostate Cancer
Volume: 7 Issue: 7
Author(s): Charles Y.F. Young
Affiliation:
Keywords: Prostate cancer, dietary chemicals, chemoprevention, epigenetic, genetic polymorphism
Abstract: In highly developed countries like USA, approximately one out of 6 in the male population will expect to have prostate cancer in their life time. Chemoprevention is presumably one of most effective means to combat many types of cancer including prostate cancer (PCa). Because clinically significant PCa usually requires more than a decade to develop, therefore, it would be an ideal target for chemoprevention. This review will focus on recent findings of the most studied, naturally occurring, synthetic or semi-synthetic chemicals for potential use in preventing PCa. Newly discovered chemicals which show potential in preventative or therapeutic effects will be included. Molecular mechanisms and gene/pathway targets by which the above agents act on target cells will be briefly discussed. The recent findings on the chemicals possessing anti-androgen receptor, anti-DNA methyltransferase, or anti-histone deacetyltransferase activity will also be presented. It will further present some important issues regarding how the interactions of chemopreventing agents with genetic polymorphisms or epigenetic factors might affect anti-cancer effects of the agents. Related large trials, if appropriate, will also be discussed.
Export Options
About this article
Cite this article as:
Young Y.F. Charles, Recent Approaches in Chemoprevention of Prostate Cancer, Current Cancer Drug Targets 2007; 7 (7) . https://dx.doi.org/10.2174/156800907782418284
DOI https://dx.doi.org/10.2174/156800907782418284 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In vitro
Current Drug Delivery Pharmacological Intervention at CCR1 and CCR5 as an Approach for Cancer: Help or Hindrance
Current Topics in Medicinal Chemistry Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant
Current Drug Therapy Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System
CNS & Neurological Disorders - Drug Targets Gene Therapy for Pituitary Tumors
Current Gene Therapy Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Current Topics in Medicinal Chemistry Glycyrrhetinic Acid and Its Derivatives: Anti-Cancer and Cancer Chemopreventive Properties, Mechanisms of Action and Structure- Cytotoxic Activity Relationship
Current Medicinal Chemistry Biomarkers to Assess the Targeting of DNA Repair Pathways to Augment Tumor Response to Therapy
Current Molecular Medicine Computational Protein Design: A Novel Path to Future Protein Drugs
Current Pharmaceutical Design Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias
Anti-Cancer Agents in Medicinal Chemistry Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Vitamin D Deficiency: Universal Risk Factor for Multifactorial Diseases?
Current Drug Targets Alpha-Secretase Cleavage of the Amyloid Precursor Protein: Proteolysis Regulated by Signaling Pathways and Protein Trafficking
Current Alzheimer Research The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Glyceraldehyde-3-phosphate Dehydrogenase from Chironomidae Showed Differential Activity Towards Metals
Protein & Peptide Letters What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?
Current Genomics From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets Connecting A Tumor to the Environment
Current Pharmaceutical Design